Der Kaninchen Polyklonal anti-RIMKLB Antikörper wird verwendet zum Nachweis von RIMKLB in Proben von Human, Maus, Ratte und Affe. Er wurde validiert für WB und ELISA.
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000,ELISA 1:5000,Not yet tested in other applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1 mg/mL
Buffer
Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C
Informationen zur Lagerung
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Haltbarkeit
12 months
Target
RIMKLB
(Ribosomal Modification Protein RimK-Like Family Member B (RIMKLB))
Andere Bezeichnung
FAM80B
Hintergrund
RIMKLB, FAM80B, KIAA1238, Beta-citryl-glutamate synthase B, N-acetyl-aspartyl-glutamate synthetase B, NAAG synthetase B, NAAGS, Ribosomal protein S6 modification-like protein BRIMKLB is a Protein Coding gene. Among its related pathways are Metabolism and Alanine, aspartate and glutamate metabolism. Beta-citryl-glutamate synthase B catalyzes the synthesis of beta-citryl-L-glutamate and N-acetyl-L-aspartyl-L-glutamate. Beta-citryl-L-glutamate is synthesized more efficiently than N-acetyl-L-aspartyl-L-glutamate. GO annotations related to this gene include glutathione synthase activity and citrate-L-glutamate ligase activity. An important paralog of this gene is RIMKLA.